Aurora Cannabis (NASDAQ:ACB – Get Free Report) will likely be announcing its earnings results before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.09) per share and revenue of $80.01 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Aurora Cannabis Price Performance
Shares of ACB stock opened at $3.65 on Monday. Aurora Cannabis has a fifty-two week low of $2.84 and a fifty-two week high of $9.35. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.88 and a current ratio of 3.83. The firm has a market capitalization of $200.23 million, a price-to-earnings ratio of -4.80 and a beta of 1.86. The stock’s 50-day simple moving average is $4.23 and its 200-day simple moving average is $5.19.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. TD Cowen assumed coverage on shares of Aurora Cannabis in a report on Wednesday, December 11th. They issued a “buy” rating for the company. TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading
- Five stocks we like better than Aurora Cannabis
- What is an Earnings Surprise?
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- What Are Dividends? Buy the Best Dividend Stocks
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The Basics of Support and Resistance
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.